Experiments for taxon Stephania tetrandra (MENISPERMACEAE)

Experiments (211 results)

Filters
Worktypes (38)
66
44
30
26
25
21
21
21
19
17
15
12
12
9
9
8
8
7
5
5
5
4
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
No match
Pharmacology (45)
11
9
8
8
5
4
3
3
3
3
3
3
3
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
110
No match
Compounds (60)
61
29
7
4
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
48
No match
Organisms (69)
19
17
16
15
12
8
7
6
6
6
4
4
4
4
4
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
211 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
752270
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE
438246
PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY
SPERM MOTILITY INCREASED
Stephania tetrandra (MENISPERMACEAE)
893867
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERTENSIVE ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE
223328
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE D
215014
MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE
223313
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE
132079
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
CASSYTHICINE
714017
PHARMACOLOGY OF EXTRACT - IN VITRO
PROTEIN SYNTHESIS INHIBITION
Stephania tetrandra (MENISPERMACEAE)
411404
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PROTEIN SYNTHESIS INHIBITION
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
110802
PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE,(+):
217030
PHARMACOLOGY OF COMPOUND - IN VITRO
ANGIOTENSIN-CONVERTING ENZYME INHIBITION
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE I
332345
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIPYRETIC ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
644302
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESIDENTIFICATION IN BY HPLCQUANTITATIVE DATACHEMOTAXONOMY MARKER CODE
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE
752285
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE C
1323732
MEDICINAL FOLKLORE REPORTED FOR
ANTIINFLAMMATORY ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
132074
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
CORYDIONE
955586
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
CORYDINE,ISO:PALMATINE,TETRAHYDRO: (-):
723491
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIISCHEMIC EFFECT
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
1300102
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR
ANTIOXIDANT ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
669894
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Stephania tetrandra (MENISPERMACEAE)
223324
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
OBLONGINE CHLORIDE
975676
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
CORYDINE,ISO:PALMATINE,TETRAHYDRO: (-):
752277
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
STEPHENANTHRINE
809634
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIPROLIFERATION ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
272919
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Stephania tetrandra (MENISPERMACEAE)
STEPHAFLAVONE A
922002
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
HYPOTENSIVE ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE
215020
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE,2-2'-N-N-DINOR:
95179
PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE D
409048
PHARMACOLOGY OF COMPOUND - IN HUMANSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SMOOTH MUSCLE RELAXANT ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
743200
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIARRHYTHMIC ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
1288230
PMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE
743196
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIARRHYTHMIC ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
752282
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
MAGNOFLORINE
223312
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
984329
PHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIHYPERTENSIVE ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
95177
PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE B
37119
MEDICINAL FOLKLORE REPORTED FOR
LAXATIVE EFFECT
Stephania tetrandra (MENISPERMACEAE)
743204
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIARRHYTHMIC ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE
409044
PHARMACOLOGY OF COMPOUND - IN VIVOMECHANISM OF ACTION STUDIEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
GANGLIONIC BLOCKING EFFECT
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
743206
PHARMACOLOGY OF COMPOUND - IN VITRO
CHRONOTROPIC EFFECT NEGATIVE
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE
332344
PHARMACOLOGY OF COMPOUND - IN VIVO
ANALGESIC ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
215018
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE E
1323733
MEDICINAL FOLKLORE REPORTED FOR
ANALGESIC ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
223317
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINIUM,2'-N-METHYL: CHLORIDE
223323
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
MAGNOFLORINE CHLORIDE
1324757
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
383866
IDENTIFICATION IN BY HPLC
Stephania tetrandra (MENISPERMACEAE)
ARISTOLOCHIC ACID IARISTOLOCHIC ACID II
385676
VOUCHER SPECIMEN REPORTED FOR
Stephania tetrandra (MENISPERMACEAE)
1269814
PHARMACOLOGY OF COMPOUND - IN HUMANSREVIEW OF
ANTIINFLAMMATORY ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
215025
PHARMACOLOGY OF COMPOUND - IN VITRO
ACETYLCHOLINESTERASE INHIBITION
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE,2-N-NOR:
569949
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYHPLC SEPARATION DATA FORISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINETETRANDRINE,(+):
1323739
PHARMACOLOGY OF COMPOUND - IN VIVO
VASCULAR PERMEABILITY DECREASED
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
1323736
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
132078
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
217027
PHARMACOLOGY OF COMPOUND - IN VITRO
ANGIOTENSIN-CONVERTING ENZYME INHIBITION
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE G
332346
PHARMACOLOGY OF COMPOUND - IN VIVO
CNS STIMULANT ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,ISO:
624376
MICROSCOPY OF
Stephania tetrandra (MENISPERMACEAE)
731913
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINETETRANDRINE,(+):
110803
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATACD SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,2-N-METHYL: (+):
1323737
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
752271
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE-2'-N-ALPHA-OXIDE
215013
MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
669895
PHARMACOLOGY OF EXTRACT - IN VIVO
LOCOMOTOR ACTIVITY DECREASE
Stephania tetrandra (MENISPERMACEAE)
878266
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANGIOTENSIN-CONVERTING ENZYME INHIBITION
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE-2(N)-BETA-OXIDE
132073
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Stephania tetrandra (MENISPERMACEAE)
STEPHADIONE
723492
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE
743199
PHARMACOLOGY OF COMPOUND - IN VITRO
MYOCARDIAL INFARCTION TREATMENT
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
223314
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE-2'-N-ALPHA-OXIDE
217029
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE I
844207
IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINETETRANDRINE,(+):BERBAMINECYCLANOLINE
809635
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INDUCTION
Stephania tetrandra (MENISPERMACEAE)
186680
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Stephania tetrandra (MENISPERMACEAE)
STEPHANIA GLUCAN ASTEPHANIA GLUCAN B
395107
SYNTHESIS OF ANALOGSWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
215021
PHARMACOLOGY OF COMPOUND - IN VITRO
ACETYLCHOLINESTERASE INHIBITION
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE,2-2'-N-N-DINOR:
272920
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Stephania tetrandra (MENISPERMACEAE)
STEPHAFLAVONE B
409045
PHARMACOLOGY OF COMPOUND - IN VIVOMECHANISM OF ACTION STUDIEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
HYPOTENSIVE ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
892086
IDENTIFICATION IN BY TLCWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTED
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINETETRANDRINE,(+):CYCLANOLINE
752278
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
ARGENTININE
389743
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLC
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,DEMETHYL:TETRANDRINE,(+):
861150
IDENTIFICATION IN BY TLCQUANTITATIVE DATAQUANTITATIVE DATA REPORTED
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
395108
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
CIRCULATION STIMULATION
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
776951
PHARMACOLOGY OF EXTRACT - IN VITRO
ACETYLCHOLINESTERASE INHIBITION
Stephania tetrandra (MENISPERMACEAE)
1324089
MEDICINAL FOLKLORE REPORTED FOR
ANALGESIC ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
1323742
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
743203
PHARMACOLOGY OF COMPOUND - IN VITRO
MYOCARDIAL INFARCTION TREATMENT
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE
217023
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE F
893100
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANGIOTENSIN-CONVERTING ENZYME INHIBITION
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLIUM HYDROXIDE,1-3-4-TRIDEHYDRO:
332348
PHARMACOLOGY OF COMPOUND - IN VIVO
ANALGESIC ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,ISO:
223325
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE A
446475
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE,2'-NOR:
752274
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINIUM,2'-N-METHYL: CHLORIDE
215024
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE,2-N-NOR:
215017
PHARMACOLOGY OF COMPOUND - IN VITRO
ACETYLCHOLINESTERASE INHIBITION
Stephania tetrandra (MENISPERMACEAE)
ATHEROSPERMOLINE
223322
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINIUM,2-2'-N-N-DIMETHYL: DICHLORIDE
95176
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE A
1000561
MEDICINAL FOLKLORE REPORTED FOR
ANTIINFLAMMATORY ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
953942
PHARMACOLOGY OF EXTRACT - IN VITRO
HMG-CO-A REDUCTASE INHIBITION
Stephania tetrandra (MENISPERMACEAE)
132077
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
NANTENINE
81841
UV SPECTRUM GIVEN FORINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINETETRANDRINE,(+):CYCLANOLINE
217026
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE H
752281
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
OBLONGINE
332343
PHARMACOLOGY OF COMPOUND - IN VIVO
ANALGESIC ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
751378
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIINFLAMMATORY ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
1137390
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODEREVIEW OF
ANTITUMOR ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
223318
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
CYCLEANINE
217028
PHARMACOLOGY OF COMPOUND - IN VITRO
ANGIOTENSIN-CONVERTING ENZYME INHIBITION
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE H
607750
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
984326
MEDICINAL FOLKLORE REPORTED FOR
DIURETIC ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
752272
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE-2'-N-BETA-OXIDE
523237
ARTICLE OF INTEREST TO THE HERB INDUSTRY
Stephania tetrandra (MENISPERMACEAE)
223326
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE B
223315
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE-2'-N-BETA-OXIDE
791823
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR
CYCLOOXYGENASE INHIBITION
Stephania tetrandra (MENISPERMACEAE)
853902
IDENTIFICATION IN BY TLCQUANTITATIVE DATA REPORTED
Stephania tetrandra (MENISPERMACEAE)
CURINETETRANDRINE,(+):CYCLEANINEBERBAMINEAROMOLINE,HOMO:CEPHARANTHINE,(+):
1297192
VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE
490617
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINETETRANDRINE,(+):CYCLANOLINE
669893
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Stephania tetrandra (MENISPERMACEAE)
215027
PHARMACOLOGY OF COMPOUND - IN VITRO
ACETYLCHOLINESTERASE INHIBITION
Stephania tetrandra (MENISPERMACEAE)
ATHEROSPERMOLINE,12-O-ACETYL:
743198
PHARMACOLOGY OF EXTRACT - IN VITRO
CHRONOTROPIC EFFECT NEGATIVE
Stephania tetrandra (MENISPERMACEAE)
215016
PHARMACOLOGY OF COMPOUND - IN VITRO
ACETYLCHOLINESTERASE INHIBITION
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE
37121
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
409046
PHARMACOLOGY OF COMPOUND - IN VIVOMECHANISM OF ACTION STUDIEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SKELETAL MUSCLE RELAXANT EFFECT(CENTRAL)
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
347804
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
INTERLEUKIN-6 RELEASE INHIBITION
Stephania tetrandra (MENISPERMACEAE)
2876
PHARMACOLOGY OF EXTRACT - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMYCOBACTERIAL ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
878265
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE-2(N)-BETA-OXIDE
342496
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
893099
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLIUM HYDROXIDE,1-3-4-TRIDEHYDRO:
1074402
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
752279
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
CYCLANOLINE
446476
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ACETYLCHOLINESTERASE INHIBITION
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE,2'-NOR:
743202
PHARMACOLOGY OF COMPOUND - IN VITRO
CHRONOTROPIC EFFECT NEGATIVE
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
332347
PHARMACOLOGY OF COMPOUND - IN VIVO
HYPOTENSIVE ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,ISO:
215023
PHARMACOLOGY OF COMPOUND - IN VITRO
ACETYLCHOLINESTERASE INHIBITION
Stephania tetrandra (MENISPERMACEAE)
ATHEROSPERMOLINE,2'-N-NOR:
217025
X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE G
381318
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAIDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
132076
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
CASSAMERIDINE
81842
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Stephania tetrandra (MENISPERMACEAE)
FANGCHIRINE,OXO:
876901
HPLC DATA REPORTEDISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINETETRANDRINE,(+):CYCLANOLINE
1298871
PHARMACOLOGY OF COMPOUND - IN VIVO
NOCICEPTIVE RESPONSE REDUCTION
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE
752275
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
CYCLEANINE
743197
PHARMACOLOGY OF EXTRACT - IN VITRO
CORONARY BLOOD FLOW DECREASED
Stephania tetrandra (MENISPERMACEAE)
723493
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIISCHEMIC EFFECT
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE
776950
VOUCHER SPECIMEN REPORTED FOR
Stephania tetrandra (MENISPERMACEAE)
223321
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
CYCLANOLINE CHLORIDE
110801
PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
37120
MEDICINAL FOLKLORE REPORTED FOR
ANTIINFLAMMATORY ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
1323741
PHARMACOLOGY OF COMPOUND - IN VIVO
ANALGESIC ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
953943
PHARMACOLOGY OF EXTRACT - IN VITRO
CALCIUM CHANNEL BLOCKER
Stephania tetrandra (MENISPERMACEAE)
752269
PHARMACOLOGY OF COMPOUND - IN VITRO
ANGIOTENSIN-CONVERTING ENZYME INHIBITION
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE CFANGCHINOLINESTEPHENANTHRINETETRANDRINE-2'-N-ALPHA-OXIDETETRANDRINE-2'-N-BETA-OXIDEFENFANGJINE BTETRANDRINE,(+):TETRANDRINIUM,2'-N-METHYL: CHLORIDETETRANDRINIUM,2-2'-N-N-DIMETHYL: CHLORIDECYCLEAHOMINEFENFANGJINE AMAGNOFLORINECYCLANOLINEFENFANGJINE D
723489
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERTENSIVE ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
127809
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,2-2'-N-N-DICHLORO-METHYL:
1074401
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
752280
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINIUM,2-2'-N-N-DIMETHYL: CHLORIDE
984327
MEDICINAL FOLKLORE REPORTED FOR
ANTIINFLAMMATORY ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
1000562
MEDICINAL FOLKLORE REPORTED FOR
ANALGESIC ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
752273
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
CYCLEAHOMINE
893866
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE
37117
MEDICINAL FOLKLORE REPORTED FOR
DIURETIC ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
743195
PHARMACOLOGY OF EXTRACT - IN VITRO
MYOCARDIAL INFARCTION TREATMENT
Stephania tetrandra (MENISPERMACEAE)
723490
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
523238
PHARMACOLOGY OF EXTRACT - IN HUMANS
NEPHROTOXIC ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
223316
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
CYCLEAHOMINE
526831
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,DEMETHYL:TETRANDRINE,(+):
752284
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE B
385677
PHARMACOLOGY OF EXTRACT - IN VITRO
TYROSINASE INHIBITION
Stephania tetrandra (MENISPERMACEAE)
409047
PHARMACOLOGY OF COMPOUND - IN VIVOMECHANISM OF ACTION STUDIEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SMOOTH MUSCLE STIMULANT ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
743201
PHARMACOLOGY OF COMPOUND - IN VITRO
CORONARY BLOOD FLOW DECREASED
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
217024
PHARMACOLOGY OF COMPOUND - IN VITRO
ANGIOTENSIN-CONVERTING ENZYME INHIBITION
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE F
1324869
PRESENT IN (REVIEW)
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
922001
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE
773239
PHARMACOLOGY OF EXTRACT - IN VITRO
NEOVASCULARIZATION INHIBITION
Stephania tetrandra (MENISPERMACEAE)
215026
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Stephania tetrandra (MENISPERMACEAE)
ATHEROSPERMOLINE,12-O-ACETYL:
215015
MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
ATHEROSPERMOLINE
1323734
SYNTHESIS OF ANALOGSISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
644303
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESIDENTIFICATION IN BY HPLCQUANTITATIVE DATACHEMOTAXONOMY MARKER CODE
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
714016
PHARMACOLOGY OF EXTRACT - IN VITRO
CALCIUM TRANSIENT INHIBITION
Stephania tetrandra (MENISPERMACEAE)
223319
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
STEPHENANTHRINE
223320
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
ARGENTININE
669892
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
752286
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE D
1323740
PHARMACOLOGY OF COMPOUND - IN VIVO
WOUND HEALING ACCELERATION
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
743205
PHARMACOLOGY OF COMPOUND - IN VITRO
CORONARY BLOOD FLOW DECREASED
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE
409043
PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY
UTERINE STIMULANT EFFECT
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
984328
MEDICINAL FOLKLORE REPORTED FOR
ANALGESIC ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
110800
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE,2-N-METHYL: (+):
752276
PHARMACOLOGY OF COMPOUND - IN VITRO
ANGIOTENSIN-CONVERTING ENZYME INHIBITION
Stephania tetrandra (MENISPERMACEAE)
CYCLEANINEOBLONGINEARGENTININE
347803
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
INTERLEUKIN-6 RELEASE INHIBITION
Stephania tetrandra (MENISPERMACEAE)
215022
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Stephania tetrandra (MENISPERMACEAE)
ATHEROSPERMOLINE,2'-N-NOR:
1323738
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
323787
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
SKELETAL MUSCLE RELAXANT EFFECT(CENTRAL)
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
381319
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAIDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE
215019
PHARMACOLOGY OF COMPOUND - IN VITRO
ACETYLCHOLINESTERASE INHIBITION
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE E
37118
MEDICINAL FOLKLORE REPORTED FOR
EXPECTORANT ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
81843
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Stephania tetrandra (MENISPERMACEAE)
STEPHENANTHRINE
752268
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
1000564
PHARMACOLOGY OF COMPOUND - IN HUMANSREVIEW OF
ANTIHYPERTENSIVE ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
323788
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SKELETAL MUSCLE RELAXANT EFFECT(CENTRAL)
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
132075
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
NANTENINE,OXO:
1324758
PHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
773238
PHARMACOLOGY OF EXTRACT - IN VITRO
NEOVASCULARIZATION INHIBITION
Stephania tetrandra (MENISPERMACEAE)
723488
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIISCHEMIC EFFECT
Stephania tetrandra (MENISPERMACEAE)
752283
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE A
892099
IDENTIFICATION IN BY TLCWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTED
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
1269813
ISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
223327
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE C
95178
PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Stephania tetrandra (MENISPERMACEAE)
FENFANGJINE C
705050
PCR ANALYSIS(PLANT)
Stephania tetrandra (MENISPERMACEAE)
1288229
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTINEUROTOXIC ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE
1000563
PRESENT IN (REVIEW)
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):
1054120
IDENTIFICATION IN BY TLCQUANTITATIVE DATA REPORTED
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINETETRANDRINE,(+):
984330
PHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIHYPERTENSIVE ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
TETRANDRINE,(+):